蓝帆医疗股份有限公司第六届董事会第三十一次会议决议公告

Group 1 - The company held its 31st meeting of the 6th Board of Directors on October 21, 2025, via electronic communication, with all 8 directors participating [2][3] - The Board proposed to lower the conversion price of the "Blue Sail Convertible Bond" due to the stock price being below 85% of the conversion price for at least 15 out of the last 30 trading days, which triggers the condition for price adjustment [3][34] - The proposed adjustment will be submitted to the shareholders' meeting for approval, and the new conversion price must not be lower than the higher of the average stock price over the 20 trading days prior to the meeting and the last trading day's price, nor lower than the latest audited net asset value per share and the par value [3][47] Group 2 - The company plans to hold the 5th extraordinary shareholders' meeting of 2025 on November 7, 2025, to discuss the proposed adjustment of the bond conversion price [8][12] - The meeting will be conducted both in-person and via online voting, with specific time slots for voting outlined [13][22] - The record date for shareholders to attend the meeting is October 31, 2025, and all registered shareholders can participate [15][18]